|
BZW2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.991260E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.636000E-03 |
| Normal-vs-Stage2 |
1.636980E-01 |
| Normal-vs-Stage3 |
1.791800E-02 |
| Normal-vs-Stage4 |
6.2142999999959E-05 |
| Stage1-vs-Stage2 |
4.324800E-01 |
| Stage1-vs-Stage3 |
3.839000E-01 |
| Stage1-vs-Stage4 |
1.397620E-02 |
| Stage2-vs-Stage3 |
1.918240E-01 |
| Stage2-vs-Stage4 |
3.743400E-03 |
| Stage3-vs-Stage4 |
1.631420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.435600E-04 |
| Normal-vs-AfricanAmerican |
1.015750E-02 |
| Normal-vs-Asian |
1.223570E-01 |
| Caucasian-vs-AfricanAmerican |
3.791400E-01 |
| Caucasian-vs-Asian |
6.038400E-01 |
| AfricanAmerican-vs-Asian |
1.820370E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.140800E-03 |
| Normal-vs-Female |
8.32530000000054E-05 |
| Male-vs-Female |
1.366360E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.477800E-02 |
| Normal-vs-Extreme_Weight |
7.736600E-03 |
| Normal-vs-Obese |
1.895230E-03 |
| Normal-vs-Extreme_Obese |
6.664600E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.694400E-01 |
| Normal_Weight-vs-Obese |
4.961600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.317800E-01 |
| Extreme_Weight-vs-Obese |
4.956400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.036000E-01 |
| Obese-vs-Extreme_Obese |
1.898760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.287500E-02 |
| Normal-vs-Age(41-60Yrs) |
2.799600E-04 |
| Normal-vs-Age(61-80Yrs) |
8.238500E-03 |
| Normal-vs-Age(81-100Yrs) |
8.525000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.353180E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.922300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.052400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.207960E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.327600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.126780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.181300E-04 |
| Normal-VS-Type2 PRCC |
4.520000E-01 |
| Normal-VS-KIRP CIMP |
3.34829997061803E-09 |
| Normal-VS-Unclassified PRCC |
9.778100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.642170E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.93950000004772E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
4.744400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.22809995295859E-09 |
| Type2 PRCC-VS-Unclassified PRCC |
1.492020E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.726500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.165200E-01 |
| Normal-vs-N1 |
1.621990E-03 |
| Normal-vs-N2 |
3.124000E-03 |
| N0-vs-N1 |
3.614000E-01 |
| N0-vs-N2 |
6.163000E-01 |
| N1-vs-N2 |
6.589000E-01 |
|
|
